NEK2 is overexpressed in a variety of human cancers, such as colon cancer [28], breast cancer [29], gastric cancer [30], hepatocellular carcinoma [40] and pancreatic cancer [41]. Here, NEK2 is linked to hepatocellular carcinoma.